Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major

Infection and Immunity

Volumn 72, Issue 8, 2004, Pages 4603-4611

  Babay, Besma E C ^a,b   Louzir, Hechmi ^a   Kebaïer, Chahnaz ^a   Boubaker, Samir ^a   Dellagi, Koussay ^a   Cazenave, Pierre André ^b,c  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b CNRS   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; INFECTION RESISTANCE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; ANIMALS, WILD; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TH1 CELLS; TH2 CELLS;

EID: 3342891118     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.8.4603-4611.2004     Document Type: Article

References (56)

1. + B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice. Clin. Exp. Immunol. 117:123-129.
2. Barral, A., E. A. Peterson, D. L. Sacks, and F. A. Neva. 1983. Late metastatic leishmaniasis in the mouse. A model for mucocutaneous disease. Am. J. Trop. Med. Hyg. 32:277-285.
3. Beebe, A. M., S. Mauze, N. J. Schork, and R. L. Coffman. 1997. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6:551-557.
4. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
5. Blackwell, J. M., G. F. Black, C. S. Peacock, E. N. Miller, D. Sibthorpe, D. Gnananandha, J. J. Shaw, F. Silveira, Z. Lins-Lainson, F. Ramos, A. Collins, and M. A. Shaw. 1997. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. Philos. Trans. R. Soc. Lond. B 352:1331-1345.
6. Bourreau, E., G. Prevot, J. Pradinaud, and P. Launois. 2001. High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment. J. Infect. Dis. 184:1628-1630.
7. Bradley, D. J. 1987. Genetics of susceptibility and resistance in the vertebrate host, p. 551-581. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. II. Academic Press, London, United Kingdom.
8. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182-1187.
9. Desjeux, P. 1996. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 14:417-423.
10. Gasim, S., A. M. Elhassan, E. A. Khalil, A. Ismail, A. M. Kadaru, A. Kharazmi, and T. G. Theander. 1998. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin. Exp. Immunol. 111:64-69.
11. Ghalib, H. W., M. R. Piuvezam, Y. A. W. Skeiley, M. Siddig, F. A. Hashim, D. M. Russo, and S. G. Reed. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Investig. 92:324-329.
12. Grimaldi, G., Jr., R. B. Tesh, and D. McMahon-Pratt. 1989. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am. J. Trop. Med. Hyg. 41:687-725.
13. Groux, H., F. Cottrez, M. Rouleau, S. Mauze, S. Antonenko, S. Hurst, T. McNeil, M. Bigler, M. G. Roncarolo, and R. L. Coffman. 1999. A transgenic model to analyse the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162:1723-1729.
14. Guenet, J. L. 1998. Wild mice as a source of genetic polymorphism. Pathol. Biol. 46:685-688.
15. Guy, R. A., and M. Belosevic. 1995. Reponse of scid mice to establishment of Leishmania major infection. Clin. Exp. Immunol. 100:440-445.
16. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Methods 6:986-994.
17. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.
18. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011-7015.
19. + T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 161:6156-6163.
20. Himmelrich, H., P. Launois. I. Maillard, T. Biedermann, F. Tacchini-Cottier, R. M. Locksley, M. Röcken, and J. A. Louis. 2000. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 164:4819-4825.
21. + T cells which react to the Leishmania major LACK antigen rapidly secrete interleukin-4 and are detrimental to the host in resistant B10.D2 mice. Infect. Immun. 67:3641-3644.
22. Julia, V., M. Rassoulzadegan, and N. Glaichenhaus. 1996. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274:421-423.
23. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141-1147.
24. Karp, C. L., S. H. El-Safi, T. A. Wynn, M. M. H. Satti, A. M. Kordofani, F. A. Hashim, M. Hag-Ali, F. A. Neva, T. B. Nutman, and D. L. Sacks. 1993. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J. Clin. Investig. 91:1644-1648.
25. Kébaïer, C., H. Louzir, M. Chenik, A. Ben Salah, and K. Dellagi. 2001. Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response. Infect. Immun. 69:4906-4915.
26. Koide, T., K. Moriwaki, K. Ikeda, H. Niki, and T. Shiroishi. 2000. Multiphenotype behavioral characterization of inbred strains derived from wild stocks of Mus musculus. Mammalian Genome 11:664-670.
27. Kopf, M., F. Brombacher, G. Köhler, G. Kienzle, K.-H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient BALB/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127-1136.
28. Laskay, T., M. Diefenbach, M. Rollinghof, and W. W. Solbach. 1995. Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 25:2220-2227.
29. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549.
30. -. Eur. J. Immunol. 25:3298-3307.
31. Lipoldova, M., M. Svobodova, M. Krulova, H. Havelkova, J. Badalova, E. Nohynkova, V. Holan, A. A. M. Hart, P. Volf, and P. Demant. 2000. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun. 1:200-206.
32. + subsets during murine Leishmania major infection. Res. Immunol. 14:28-32.
33. Louzir, H., P. C. Melby, A. Ben Salah, H. Marrakchi, K. Aoun, R. Ben Ismail, and K. Dellagi. 1998. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. J. Infect. Dis. 177:1687-1695.
34. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 4:471-481.
35. + T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice. Eur. J. Immunol. 31:1288-1296.
36. Matthews, D. J., C. L. Emson, G. J. McKenzie, M. E. Jolin, J. M. Blackwell, and A. N. McKenzie. 2000. IL-13 is a susceptibility factor for Leishmania major infection. J. Immunol. 164:1458-1462.
37. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553-1559.
38. Meddeb-Garnaoui, A., S. Gritli, S. Garbouj, M. Ben Fadhel, R. El Kares, L. Mansour, B. Kaabi, L. Chouchane, A. Ben Salah, and K. Dellagi. 2001. Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to Mediterranean visceral leishmaniasis. Hum. Immunol. 62:509-517.
39. Melby, P. C., F. A. Neva, and D. L. Sacks. 1989. Profile of human T cell response to leishmanial antigens: analysis by immunoblotting. J. Clin. Investig. 83:1868-1875.
40. Melby, P. C., F. J. Andrade-Narvaez, B. J. Darnell, G. Valencia-Pacheco, V. V. Tryon, and A. Palomo-Cetina. 1994. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect. Immun. 62:837-842.
41. Mohrs, M., B. Ledermann, G. Kohler, A. Dorfmuller, A. Gessner, and F. Brombacher. 1999. Differences between IL-4- and IL-4 receptor α-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J. Immunol. 162:7302-7308.
42. Mosser, D. M., and A. Brittingham. 1997. Leishmania, macrophages and complement: a tale of subversion and exploitation. Parasitology 115:9-23.
43. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z.-E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563-566.
44. Peters, W., and R. Killick-Kendrick. 1987. The leishmaniases in biology and medicine. Clinical aspects and control, 2nd ed. Academic Press, London, United Kingdom.
45. Pirmez, C., M. Yamamura, K. Uyemura, M. Paes-Oliveira, F. Conceicao-Silva, and R. L. Moddin. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Investig. 51:1390-1395.
46. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
47. Roberts, L. J., T. M. Baldwin, J. M. Curtis, E. Handman, and S. J. Foote. 1997. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and chromosome 9. J. Exp. Med. 185:1705-1710.
48. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845-858.
49. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-IL-4 monoclonal antibody. Evidence for a T cell-dependent, interferon-gamma-independent mechanism. J. Exp. Med. 171:115-127.
50. Sassi, A., H. Louzir, A. Ben Salah, M. Mokni, A. Ben Osman, and K. Dellagi. 1999. Leishmanin skin test lymphoproliferative response and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clin. Exp. Immunol. 116:127-132.
51. Schlein, Y. 1993. Leishmania and sandflies: interactions in the life cycle and transmission. Parasitol. Today 9:255-258.
52. Scott, P., and J. P. Farrell. 1998. Experimental cutaneous leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major. Chem. Immunol. 70:60-80.
53. Sypek, J. P., C. L. Chung, S. E. H. Mayor, S. J. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
54. + cells are indispensable for ulcer development in murine cutaneous leishmaniasis. Infect. Immun. 68:4574-4577.
55. Varkila, K., R. Chatelain, L. M. Leal, and R. L. Coffman. 1993. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type 1 response and renders them capable of healing Leishmania major infection. Eur. J. Immunol. 23:262-268.
56. WHO Expert Committee. 1990. Control of leishmaniasis, p. 158. WHO Technical Report Series. World Health Organization, Geneva, Switzerland.